Avanos Medical, Inc.
Market Cap
$632.91M
P/E Ratio
-8.67
EPS
$-1.57
Dividend Yield
0.00%
52-Week Range
$9.30 — $15.68
Volume
447.45K
Avg Volume
613.35K
Beta
1.09
P/E (TTM)
-8.67
Forward P/E
13.61
PEG Ratio
-0.10
P/S (TTM)
0.87
P/B (TTM)
0.78
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.09%
ROA (TTM)
-0.06%
ROIC
—
Gross Margin
0.50%
Operating Margin
-0.09%
Net Margin
—
Debt/Equity
0.17
Current Ratio
2.15
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.11%
EPS Growth (5Y)
+0.26%
Sales Growth (3Y)
-0.03%
Sales Growth (5Y)
-0.00%
EPS Est (This Year)
$1.00
EPS Est (Next Year)
$1.25
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.94
Price Target Range
Consensus Target: $23.00(69.0% upside)
Institutional %
14.94%
Inst. Net Change
382.82K
Insider Net Shares (90d)
—
Outstanding Shares
46.50M
Float
42.24M
Free Float %
90.83%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NYSE
IPO Date
2014-10-21
Employees
2227
CEO
David C. Pacitti
Index Membership
—
Website
https://avanos.com
Avanos Medical, Inc. (AVNS) is a healthcare company in the medical - devices industry listed on the NYSE. With a market capitalization of $632.91M, a P/E ratio of -8.67, AVNS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AVNS against other stocks using dozens of fundamental and technical filters.
Avanos Medical, Inc. (AVNS) has a trailing twelve-month (TTM) P/E ratio of -8.67. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Avanos Medical, Inc. (AVNS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Avanos Medical, Inc. (AVNS) has a market capitalization of $632.91 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.